Risk-based quality management (RBQM) aims to detect the right signals early enough to prevent an issue from occurring. To ...
In today’s ACT Brief, we examine why outdated views of Asia Pacific trial sites persist, how community access gaps reflect ...
In this video interview, James Cheong, senior vice president of Asia Pacific at Precision for Medicine, explains how FDA ...
ACT Brief: Capturing Trial Friction, AI Matching Model Comparisons, and Boehringer’s Oncology Deal
In today’s ACT Brief, we examine how capturing friction in real time can reveal site burden, how OpenAI and Mistral compare ...
In this video interview, James Cheong, senior vice president of Asia Pacific at Precision for Medicine, explains how regulatory reform and inspection data contradict the view that APAC sites are ...
The planned sites in Livonia, Las Vegas, and San Antonio would expand a partnership that places clinical research and health ...
In this video interview, Kent Thoelke, CEO of Paradigm Health, describes how manual eligibility screening and swivel-chair ...
Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, management, and monitoring.
Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, management, and monitoring.
In this Q&A, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, discusses ...
In this video interview, Kent Thoelke, CEO of Paradigm Health, calls for safe harbor protections, CMS reimbursement ...
Neuroscience trials struggle to show benefit because symptoms are subjective and variable, and eCOA strengthens dossiers by standardizing ClinRO administration, capturing outcomes in real time to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results